US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
US5229129A
(en)
*
|
1989-07-12 |
1993-07-20 |
Cygnus Therapeutic Systems |
Transdermal administration of lisuride
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
EP0523150A4
(en)
*
|
1990-04-06 |
1993-09-29 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
US5225198A
(en)
*
|
1991-08-27 |
1993-07-06 |
Cygnus Therapeutic Systems |
Transdermal administration of short or intermediate half-life benzodiazepines
|
US5705185A
(en)
*
|
1991-09-25 |
1998-01-06 |
Beta Pharmaceuticals Co. |
Transdermal delivery of estradiol and process for manufacturing said device
|
US5518734A
(en)
*
|
1991-09-25 |
1996-05-21 |
Beta Pharmaceuticals Co. |
Transdermal delivery system for estradiol and process for manufacturing said device
|
US5229130A
(en)
*
|
1991-12-20 |
1993-07-20 |
Cygnus Therapeutics Systems |
Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
|
US5453279A
(en)
*
|
1992-04-21 |
1995-09-26 |
Tbs Laboratories, Inc. |
Enhancing transdermal absorption compositions; transdermal dosage form; and process
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
JPH0827003A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sekisui Chem Co Ltd |
経皮吸収製剤
|
DK0781122T3
(da)
|
1994-09-14 |
2000-10-30 |
Minnesota Mining & Mfg |
Matrix til transdermal lægmiddelafgivelse
|
GB9500116D0
(en)
*
|
1995-01-05 |
1995-03-01 |
Ciba Geigy Ag |
Pharmaceutical compositions
|
US5573778A
(en)
*
|
1995-03-17 |
1996-11-12 |
Adhesives Research, Inc. |
Drug flux enhancer-tolerant pressure sensitive adhesive composition
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
DK1563788T3
(da)
|
1995-08-29 |
2015-05-11 |
Nitto Denko Corp |
Mikroperforering af human hud til stofindgift og overvågningsformål
|
DE19548332A1
(de)
*
|
1995-12-22 |
1997-07-10 |
Rotta Res Bv |
Hormonpflaster
|
AU2036297A
(en)
*
|
1996-03-20 |
1997-10-10 |
Glaxo Group Limited |
Topical formulations of aciclovir
|
IT1283102B1
(it)
*
|
1996-06-06 |
1998-04-07 |
Permatec Nv |
Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
|
DK0934078T3
(da)
*
|
1996-10-24 |
2003-04-14 |
Alza Corp |
Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
|
JP2001503062A
(ja)
*
|
1996-10-30 |
2001-03-06 |
セラテック・インコーポレーテッド |
透過促進剤としての乳酸の脂肪酸エステルの塩
|
KR100294084B1
(ko)
*
|
1998-06-02 |
2001-09-22 |
성재갑 |
비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
|
KR100215027B1
(ko)
*
|
1997-01-27 |
1999-08-16 |
성재갑 |
스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
|
US6572874B1
(en)
*
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
IT1294748B1
(it)
|
1997-09-17 |
1999-04-12 |
Permatec Tech Ag |
Formulazione per un dispositivo transdermico
|
US6046244A
(en)
*
|
1997-11-05 |
2000-04-04 |
Nexmed Holdings, Inc. |
Topical compositions for prostaglandin E1 delivery
|
US6414028B1
(en)
*
|
1997-11-05 |
2002-07-02 |
Nexmed Holdings, Inc. |
Topical compositions containing prostaglandin E1
|
US6267984B1
(en)
|
1997-12-22 |
2001-07-31 |
Alza Corporation |
Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
AR018330A1
(es)
*
|
1998-04-27 |
2001-11-14 |
Fujisawa Pharmaceutical Co |
Composiciones farmaceuticas que comprenden macrolidos como agentes activos para la terapia y profilaxis de las enfermedades de la piel
|
FR2761600B1
(fr)
*
|
1998-06-19 |
2000-03-31 |
Oreal |
Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
|
GB9825402D0
(en)
†
|
1998-11-19 |
1999-01-13 |
Pfizer Ltd |
Antiparasitic formulations
|
US20030078499A1
(en)
*
|
1999-08-12 |
2003-04-24 |
Eppstein Jonathan A. |
Microporation of tissue for delivery of bioactive agents
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
EP1307232B1
(de)
*
|
2000-08-03 |
2007-03-07 |
Antares Pharma IPL AG |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
DE10041478A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8728445B2
(en)
|
2001-05-01 |
2014-05-20 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences |
Hydrogel Compositions
|
DE60239528D1
(de)
|
2001-05-01 |
2011-05-05 |
Corium International Redwood City |
Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
NZ532769A
(en)
*
|
2001-11-29 |
2005-12-23 |
3M Innovative Properties Co |
Pharmaceutical formulations comprising an immune response modifier
|
DE10159120B4
(de)
*
|
2001-12-01 |
2006-08-17 |
Lts Lohmann Therapie-Systeme Ag |
Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
US9918665B2
(en)
|
2002-03-11 |
2018-03-20 |
Nitto Denko Corporation |
Transdermal porator and patch system and method for using same
|
EP3061492B1
(de)
|
2002-03-11 |
2018-09-19 |
Nitto Denko Corporation |
Patch-system zur transdermalen arzneimittelverabreichung
|
US8116860B2
(en)
*
|
2002-03-11 |
2012-02-14 |
Altea Therapeutics Corporation |
Transdermal porator and patch system and method for using same
|
US20030199584A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Ahluwalia Gurpreet S. |
Reduction of hair growth
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
EP1530469B1
(de)
*
|
2002-08-20 |
2009-02-25 |
Euro-Celtique S.A. |
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
|
EP1556501A4
(de)
|
2002-10-28 |
2009-04-08 |
Transform Pharmaceuticals Inc |
Transdermaler assay mit magnetischerklemme
|
ATE295726T1
(de)
*
|
2002-12-02 |
2005-06-15 |
Sanol Arznei Schwarz Gmbh |
Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
JP4542743B2
(ja)
*
|
2002-12-26 |
2010-09-15 |
Kdl株式会社 |
ピリドン誘導体の溶液状医薬組成物
|
DE10261696A1
(de)
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
US7858607B2
(en)
*
|
2003-03-14 |
2010-12-28 |
Mamchur Stephen A |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
|
US20040241223A1
(en)
*
|
2003-05-27 |
2004-12-02 |
David Wong |
Oral dosage forms for macromolecular drugs
|
US7576226B2
(en)
*
|
2003-06-30 |
2009-08-18 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process of making isomers of norelgestromin and methods using the same
|
US7888546B2
(en)
|
2003-07-03 |
2011-02-15 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and IV hold-down, and method relating to same
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
MXPA06003316A
(es)
|
2003-10-10 |
2006-06-08 |
Antares Pharma Ipl Ag |
Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
|
US8016811B2
(en)
|
2003-10-24 |
2011-09-13 |
Altea Therapeutics Corporation |
Method for transdermal delivery of permeant substances
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
CN1929819B
(zh)
|
2004-01-30 |
2012-02-29 |
考里安国际公司 |
递送活性剂的快速溶解膜
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
WO2006019823A2
(en)
*
|
2004-07-15 |
2006-02-23 |
Freedom-2, Llc |
Modified tissue marking pigment and method for modifying tissue marking pigment
|
RU2393877C2
(ru)
|
2004-08-05 |
2010-07-10 |
Кориум Интернэшнл, Инк. |
Адгезивная композиция
|
JP5199678B2
(ja)
|
2005-02-23 |
2013-05-15 |
プレクサ ファーマシューティカルズ, インコーポレイテッド |
運動障害および他のcns適応症の処置に使用することにおけるドーパミントランスポータ阻害剤
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
US10137135B2
(en)
*
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
DE102006050558B4
(de)
*
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
WO2009018356A1
(en)
*
|
2007-07-30 |
2009-02-05 |
Medacure International, Inc. |
Immune system modulator formulation
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
US8658699B2
(en)
*
|
2008-05-19 |
2014-02-25 |
Massachusetts Institute Of Technology |
Chemical permeation enhancers enhance nerve blockade by toxins
|
WO2009143175A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
US8784879B2
(en)
|
2009-01-14 |
2014-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
US20120277629A1
(en)
|
2011-04-29 |
2012-11-01 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collection and/or manipulation of blood spots or other bodily fluids
|
WO2012018486A2
(en)
|
2010-07-26 |
2012-02-09 |
Seventh Sense Biosystems, Inc. |
Rapid delivery and/or receiving of fluids
|
WO2010101620A2
(en)
|
2009-03-02 |
2010-09-10 |
Seventh Sense Biosystems, Inc. |
Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin
|
US20110288389A9
(en)
|
2009-03-02 |
2011-11-24 |
Seventh Sense Biosystems, Inc. |
Oxygen sensor
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
WO2011000210A1
(zh)
*
|
2009-07-01 |
2011-01-06 |
润和生物医药科技(汕头)有限公司 |
促渗剂组合物及其透皮给药系统中的应用
|
AU2010279384A1
(en)
|
2009-08-05 |
2012-03-01 |
Wake Forest University |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
WO2011094573A1
(en)
|
2010-01-28 |
2011-08-04 |
Seventh Sense Biosystems, Inc. |
Monitoring or feedback systems and methods
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
WO2011163347A2
(en)
|
2010-06-23 |
2011-12-29 |
Seventh Sense Biosystems, Inc. |
Sampling devices and methods involving relatively little pain
|
WO2012009613A1
(en)
|
2010-07-16 |
2012-01-19 |
Seventh Sense Biosystems, Inc. |
Low-pressure environment for fluid transfer devices
|
WO2012021801A2
(en)
|
2010-08-13 |
2012-02-16 |
Seventh Sense Biosystems, Inc. |
Systems and techniques for monitoring subjects
|
WO2012064802A1
(en)
|
2010-11-09 |
2012-05-18 |
Seventh Sense Biosystems, Inc. |
Systems and interfaces for blood sampling
|
WO2012149155A1
(en)
|
2011-04-29 |
2012-11-01 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collecting fluid from a subject
|
EP2701600B1
(de)
|
2011-04-29 |
2016-06-08 |
Seventh Sense Biosystems, Inc. |
Ausgabe und/oder aufnahme von flüssigkeiten
|
US20130158468A1
(en)
|
2011-12-19 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving material with respect to a subject surface
|
MX2014002115A
(es)
*
|
2011-08-25 |
2014-09-25 |
Nipro Patch Co Ltd |
Parche de piel adhesivo hidratado.
|
DE102011119043A1
(de)
|
2011-11-22 |
2013-05-23 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System (TDS) mit Rotigotin
|
WO2013112947A1
(en)
*
|
2012-01-26 |
2013-08-01 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PL2782584T3
(pl)
|
2011-11-23 |
2021-12-13 |
Therapeuticsmd, Inc. |
Naturalne skojarzone hormonalne formulacje i terapie zastępcze
|
US20130338122A1
(en)
*
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10258682B2
(en)
|
2013-01-16 |
2019-04-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Attenuated chlamydia vaccine
|
PE20160011A1
(es)
|
2013-03-15 |
2016-02-10 |
Childrens Medical Center |
Formulaciones combinadas de neosaxitoxina para una anestesia local prolongada
|
AU2014251207B2
(en)
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
EP3071199A2
(de)
|
2013-11-22 |
2016-09-28 |
Genzyme Corporation |
Neuartiges verfahren zur behandlung neurodegenerativer erkrankungen
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
KR20160101073A
(ko)
|
2013-12-20 |
2016-08-24 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
US10993997B2
(en)
|
2014-12-19 |
2021-05-04 |
The Broad Institute, Inc. |
Methods for profiling the t cell repertoire
|
MY190974A
(en)
|
2015-05-20 |
2022-05-25 |
Massachusetts Gen Hospital |
Shared neoantigens
|
JP7257739B2
(ja)
*
|
2015-07-02 |
2023-04-14 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
レボノルゲストレルおよびエチニルエストラジオールのための経皮的薬物送達システム
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017184590A1
(en)
|
2016-04-18 |
2017-10-26 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|